masthead



                                         

Program 1 of 3 Scroll down to see them all.

This program provides brand name medications at no or low cost.
Pharmaceutical Company United Therapeutics Corporation
Program Name United Therapeutics Bridge Patient Assistance program for Remodulin and Tyvaso
Program Address
Phone Number

1-877-242-2738, 1-866-474-8326

Fax Number
Medications on Program Remodulin Injection  (treprostinil sodium)
Application Forms Not Applicable
On-line Application
No on-line application available at this time
Web Site No link available.
Eligibility Guidelines and Notes

Those with federal health care or Massachusetts state coverage are not eligible.  Patient must have less than $25,000 in monthly household income AND meet one or more of the following: 1)has changed jobs or stopped working and has COBRA or HIPAA coverage 2) has insurance, but has exclusion period.  The medication must be used for a FDA-approved diagnosis. Patient must reside in the US, be under the direct care of a licensed US physician and receive health care services via the US health care system. Another number for the program is 866-344-4874. Patient will be excluded from this program if they lose insurance coverage by accepting PAP product. Patient financial, medication and insurance information is collected and reevaluated quarterly.

Application Process

The doctor or patient can call to request an application.      

Application Requirements

The doctor must fill out a section and sign the application. The patient must also complete, sign the application and attach proof of income.

Program Details

The medication is sent to either the doctor's office or the patient's home.  Patient are eligible for a maximum of six months or until they are able to obtain third party insurance, whichever comes first.

Last Updated August 17, 2010


                                         

Program 2 of 3 Scroll down to see them all.

This program provides brand name medications at no or low cost.
Pharmaceutical Company United Therapeutics Corporation
Program Name United Therapeutics Indigent Patient Assistance Program for Remodulin and Tyvasco
Program Address
Phone Number

877-242-2738, 866-474-8326

Fax Number
Medications on Program Remodulin Injection  (treprostinil sodium)
Application Forms Not Applicable
On-line Application
No on-line application available at this time
Web Site No link available.
Eligibility Guidelines and Notes

Those with federal health care or Massachusetts state coverage are not eligible.  Patients must meet the following criteria: 1) Insufficient financial resources to pay for treatment 2)Income is not more than 300% FPL and patient has documented proof that they don't have insurance coverage 3)A written denial from a state Medicaid program. The medication must be used for a FDA-approved diagnosis. Patient must reside in the US, be under the direct care of a licensed US physician and receive health care services via the US health care system.  This program is available through 3 distributors, patients may also call 1-866-474-8326. Income, medication and insurance verification will be required quarterly.

Application Process

The doctor or patient can call to request an application. The application can be either faxed or mailed out upon request.     

Application Requirements

The doctor must fill out a section and sign the application. The patient must fill out a section, sign the application and attach proof of income and any insurance information.

Program Details

Not applicable.

Last Updated August 17, 2010


                                         

Program 3 of 3.

This program provides brand name medications at no or low cost.
Pharmaceutical Company United Therapeutics Corporation
Program Name United Therapeutics Lifetime Cap Assistance Program for Remodulin and Tyvaso
Program Address
Phone Number

866-474-8326, 866-344-4874

Fax Number
Medications on Program Remodulin Injection  (treprostinil sodium)
Application Forms Not Applicable
On-line Application
No on-line application available at this time
Web Site No link available.
Eligibility Guidelines and Notes

Patient mustn't have access to coverage from fed govt or MA programs. They may have insurance coverage BUT the only source of coverage is a policy with a lifetime cap on benefits and the patient is within $300,000 of reaching that lifetime cap. Has a household income below $25,000. The medication must be used for a FDA-approved diagnosis. Patient must reside in the US, be under the direct care of a licensed US physician and receive health care services via the US health care system. The patient may also call 1-877-242-2738. A statement from the insurer documenting that the patient is within $300,000 of exhausting a lifetime cap on his or her insurance benefits is required. Eligibility terminates if the patient obtains new insurance. Patient household income and insurance status is re-evaluated quarterly.

Application Process

The doctor or patient can call to request an application. The application can be either faxed or mailed out upon request.     

Application Requirements

The doctor must fill out a section and sign the application. The patient must fill out a section, sign the application and attach proof of income and any insurance information.

Program Details

Not applicable.

Last Updated August 17, 2010